230. Alveolar hypoventilation syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 9 /  Drugs : 13 - (DrugBank : 6) / Drug target genes : 17 - Drug target pathways : 27

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Acetazolamide
   Hospital Son Llatzer
      2011   Phase 3   NCT01499485   Spain
   ISTITUTO AUXOLOGICO ITALIANO
      2022   Phase 2   EUCTR2022-000693-26-IT   Italy
AD981
   Istituto Auxologico Italiano
      2022   Phase 2   NCT05448443   Italy
Atomoxetina
   ISTITUTO AUXOLOGICO ITALIANO
      2022   Phase 2   EUCTR2022-000693-26-IT   Italy
Cerazette
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2011-000989-35-FR   France
Desogestrel
   Assistance Publique - Hôpitaux de Paris
      2011   Phase 2/Phase 3   NCT01243697   France
   Children's Hospital Los Angeles
      2012   -   NCT01500473   United States
Diamox
   ISTITUTO AUXOLOGICO ITALIANO
      2022   Phase 2   EUCTR2022-000693-26-IT   Italy
Domperidone
   Karolinska Universitetssjukhuset
      2006   Phase 2   EUCTR2005-005950-33-SE   Sweden
Désogestrel
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2011-000989-35-FR   France
Honey
   The Seventh Affiliated Hospital of Sun Yat-sen University (Shenzhen)
      2024   -   ChiCTR2400080345   China
Motilium
   Karolinska Universitetssjukhuset
      2006   Phase 2   EUCTR2005-005950-33-SE   Sweden
Phase 2. continous/bilevel positive airway presure with additional oxygen support BY devilbiss 525 KS oxygen concentrator
   Pauls Stradins Clinical University Hospital
      2023   -   NCT06090149   Latvia
Strattera
   ISTITUTO AUXOLOGICO ITALIANO
      2022   Phase 2   EUCTR2022-000693-26-IT   Italy
Water
   The Seventh Affiliated Hospital of Sun Yat-sen University (Shenzhen)
      2024   -   ChiCTR2400080345   China